GlassScriptPhysician profile
Atul Poudel
NPI 1447674858
$1,552.36
in general payments reported to CMS, 2019-2025
12 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $33.98 · 2021: $100 · 2022: $200 · 2023: $289 · 2024: $494 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.64 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $619.78 | 2019-2024 | Ultomiris, Soliris |
| Bayer Healthcare Pharmaceuticals INC. | $245.79 | 2024 | |
| Baxter Healthcare | $141.33 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $133.56 | 2025 | |
| Amgen INC. | $95.68 | 2023 | Tavneos |
| Calliditas Therapeutics US INC. | $82.21 | 2023 | Tarpeyo |
| Glaxosmithkline, LLC. | $74.10 | 2021 | |
| Alnylam Pharmaceuticals INC. | $63.91 | 2021-2025 | Givlaari |
| Nuwellis, INC. | $33.84 | 2025 | Aquadex Smartflow Console |
| Mallinckrodt Enterprises LLC | $26.24 | 2019 | |
| Tris Pharma INC | $18.46 | 2023 | Quillichew Er |
| Ultragenyx Pharmaceutical INC. | $17.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atul Poudel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.